Form 4: OptiNose Director John Fletcher Acquires 85,000 Stock Options
SEC Form 4 Filing
Director John Fletcher acquired 85,000 stock options in OptiNose, Inc. on June 6, 2024.
Summary
- On June 6, 2024, John Fletcher, a director of OptiNose, Inc., acquired 85,000 stock options.
- The exercise price of these options is $1.04.
- The options vest on the earlier of June 6, 2025, or the Issuer's 2025 annual meeting of stockholders, contingent upon continued service with the Issuer.
- The options expire on June 6, 2034.
- Following the transaction, Fletcher directly owns 85,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, indicating a standard transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock option grants to a company director, which is a common practice in publicly traded companies to incentivize and align the interests of management with shareholders.
Stakeholder Impact
- The acquisition of stock options by a director can align their interests with those of shareholders, potentially encouraging decisions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date of transaction: John Fletcher acquired 85,000 stock options. |
| 06/06/2025 | Earliest vesting date for the options, contingent upon continued service. |
| 06/06/2034 | Expiration date of the stock options. |
| 06/07/2024 | Date of signature of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.